Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Identifying employed multiple sclerosis patients at-risk for job loss: When do negative work events pose a threat?
Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases.
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.
Remyelination of the Corpus Callosum by Olfactory Ensheathing Cell in an Experimental Model of Multiple Sclerosis.
The triggering receptor expressed on myeloid cells 2 - a molecular link of neuroinflammation and neurodegenerative diseases.
Illuminating vitamin D effects on B-cells - the multiple sclerosis perspective.
Sarcoidosis with neurological involvement imitating multiple sclerosis: The importance of thoracic imaging.
Cholesterol in myelin biogenesis and hypomyelinating disorders.
Association of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism With Multiple Sclerosis in Turkish Patients.
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment.
The correlation of HLA-G with multiple sclerosis.
Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.
New tools for studying microglia in the mouse and human CNS.
Cost-effectiveness of an adjustment group for people with multiple sclerosis and low mood: a randomized trial.
PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions.
Teriflunomide for the treatment of multiple sclerosis.
An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion.
Serum NSE and multiple sclerosis.
[Foix-Chavany-Marie syndrome presenting as multiple sclerosis].
Correction: An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Comparison of Intelligibility Measures for Adults with Parkinson's Disease, Multiple Sclerosis and Healthy Controls.
Primary spinal oligoastrocytoma mimicking longitudinally extensive transverse myelitis.
Pages
« first
‹ previous
…
550
551
552
553
554
555
556
557
558
…
next ›
last »